Onesource Specialty Pharma: Disclosure Under Regulation 29(2) Of SEBI (SAST) Regulations 2011 And Regulation 7(2) Of SEBI (PIT) Regulations 2015

Disclosure under Regulation 29(2) of SEBI (SAST) Regulations 2011 and Regulation 7(2) of SEBI (PIT) Regulations 2015. Promoter entity (Tenshi Pharmaceuticals Private Limited) has purchased 2 00 000 equity shares of the Company from the market on January 28 2026.